You are here: Industry Insights > Market News > China, U.S. to send COVID-19 vaccine doses to El Salvador

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Brexpiprazole Intermediate CAS:70500-72-0

Brexpiprazole CAS:913611-97-9

3-BROMOPHENANTHRENE

2-FLUORO-4-(TRIFLUOROMETHYL)BENZOPHENONE

3-BROMO-4-FLUOROBIPHENYL

9-TRIFLUOROACETYLANTHRACENE

China, U.S. to send COVID-19 vaccine doses to El Salvador

firstwordpharmaJuly 05, 2021

Tag: Moderna , Vaccine , COVID-19

Favorites

China will send 1.5 million Sinovac COVID-19 vaccines to El Salvador, the Chinese Embassy there announced on Friday, as reported by the National Post.

China, U.S. to send COVID-19 vaccine doses to El Salvador

The announcement came after the White House said the US would send 1.5 million Moderna vaccines to the Central American country.

China said it would send the vaccines in the next few days, while White House press secretary Jen Psaki said the US would send the Moderna doses on Sunday.

Previous:Bharat Biotech Concludes Final Analysis for COVAXIN Efficacy from Phase 3 Clinical Trials

Next:SAHPRA Authorises the CoronaVac Vaccine with Conditions

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

China, U.S. to send COVID-19 vaccine doses to El Salvador | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

Poliomyelitis (Live) Vaccine Type I Type III (Human Diploid Cell), Oral

B11 100ml amber plastic vaccine bottle

Influenza Vaccine by Hualan Bio

Poliomyelitis Vaccine Type I Type III in Dragee Candy (Human Diploid Cell), Live

Inactivated Influenza Vaccine(Split Virion) manufactured by Hualan Bio

Hualan H7N9 Inactivated Influenza Vaccine by Hualan Bio

High-standard Influenza Vaccine (Split virion), inactivated

H7N9 Inactivated Influenza Vaccine-HUALAN BIO

flu vaccine for 2023-2024 northern hemisphere influenza season

Ruminant Vaccine Series

China, U.S. to send COVID-19 vaccine doses to El Salvador

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

You may likeMore>>

You may like
More>>